FFA
BNTX icon

Farther Finance Advisors’s BioNTech BNTX Stock Holding History

Farther Finance Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.5K Buy
493
+118
+31% +$11.5K ﹤0.01% 3450
2026
Q2 		$34.9K Buy
375
+41
+12% +$3.86K ﹤0.01% 3538
2026
Q1 		$29.9K Buy
334
+163
+95% +$16.8K ﹤0.01% 3372
2025
Q4 		$16.3K Sell
171
-17
-9% -$1.71K ﹤0.01% 3575
2025
Q3 		$18.5K Buy
188
+181
+2,586% +$19.4K ﹤0.01% 3097
2025
Q2 		$730 Sell
7
-25
-78% -$2.52K ﹤0.01% 3965
2025
Q1 		$2.89K Sell
32
-28
-47% -$3.13K ﹤0.01% 3248
2024
Q4 		$6.84K Buy
60
+59
+5,900% +$6.73K ﹤0.01% 2535
2024
Q3 		$119 Sell
1
-55
-98% -$5.06K ﹤0.01% 3748
2024
Q2 		$4.41K Buy
+56
New +$5.12K ﹤0.01% 2451
2023
Q4 		– Sell
-10
Closed -$1.09K – 3554
2023
Q3 		$1.09K Buy
10
+9
+900% +$995 ﹤0.01% 2060
2023
Q2 		$108 Hold
1
– – ﹤0.01% 2423
2023
Q1 		$125 Sell
1
-34
-97% -$4.67K ﹤0.01% 2267
2022
Q4 		$5.26K Buy
+35
New +$5.39K ﹤0.01% 1152

Other funds holding BNTX

CCP
Crocodile Capital Partners Ursensollen, Germany $160M AUM 18.68% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's BNTX Position: Q3 2026 in Review

Farther Finance Advisors increased its BioNTech (BNTX) stake by 31% in Q3 2026, buying an estimated $11.5K and bringing the position to 493 shares worth $48.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3450.

Farther Finance Advisors first reported a position in BNTX in Q4 2022 and has held it in 14 quarters since. 5 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Farther Finance Advisors held 493 shares of BioNTech worth $48.5K as of Q3 2026.
  • Farther Finance Advisors bought 118 BioNTech shares in Q3 2026, an estimated $11.5K.
  • BioNTech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3450 holding.
  • Farther Finance Advisors first reported a position in BioNTech in Q4 2022 and has held it in 14 quarters since.
  • 5 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.